curcumin and Thromboembolism

Curcumin, the main ingredient of Curcuma longa L., has been used as a spice and as a herbal medicine with different therapeutic characteristics for centuries in Asian countries. This phytochemical has been shown to possess beneficial antiplatelet activity that has introduced it as a promising candidate for the treatment of thromboembolism, atherothrombosis, and inflammatory diseases. Platelet dysfunction under different circumstances may lead to cardiovascular disease, and curcumin has been shown to have beneficial effects on platelet dysfunction in several studies. Therefore, this narrative review is aimed to summarize available evidence on the antiplatelet activity of curcumin and related molecular mechanisms for this activity.

Topics: Animals; Blood Coagulation; Blood Platelets; Coronary Restenosis; Curcuma; Curcumin; Humans; Mice; Neovascularization, Physiologic; Platelet Activation; Platelet Aggregation Inhibitors; Rats; Thromboembolism; Thrombosis